Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01120678 · ClinicalTrials.gov registry record
Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 250
- Enrollment target
NCT01120678: Completed study, sponsored by University of Virginia.
NCT01120678 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01120678 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients \>3 days of age.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-07 |
What the finished NCT01120678 record still lists
NCT01120678 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01120678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01120678 about?
NCT01120678 is a clinical study titled "Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay". The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients \>3 days of age.
What is the current status of trial NCT01120678?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2009-02. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT01120678?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia